For AML patients with low- and high-expressed siglec14, there were a total of 1086 significantly differentially expressed genes (|log2(FC)|> 1.5 and p.adj < 0.05), including 757 up-regulated genes and 329 down-regulated genes (Fig. 6B). This evidence concerns the gene SIGLEC14 and acute myeloid leukemia.